181 related articles for article (PubMed ID: 23936228)
1. SHBG is an important factor in stemness induction of cells by DHT in vitro and associated with poor clinical features of prostate carcinomas.
Ma Y; Liang D; Liu J; Wen JG; Servoll E; Waaler G; Sæter T; Axcrona K; Vlatkovic L; Axcrona U; Paus E; Yang Y; Zhang Z; Kvalheim G; Nesland JM; Suo Z
PLoS One; 2013; 8(7):e70558. PubMed ID: 23936228
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effect of SCF and G-CSF on stem-like properties in prostate cancer cell lines.
Ma Y; Liang D; Liu J; Axcrona K; Kvalheim G; Giercksky KE; Nesland JM; Suo Z
Tumour Biol; 2012 Aug; 33(4):967-78. PubMed ID: 22252524
[TBL] [Abstract][Full Text] [Related]
3. Characterization of OCT3/4, Nestin, NANOG, CD44 and CD24 as stem cell markers in canine prostate cancer.
Costa CD; Justo AA; Kobayashi PE; Story MM; Palmieri C; Laufer Amorim R; Fonseca-Alves CE
Int J Biochem Cell Biol; 2019 Mar; 108():21-28. PubMed ID: 30633985
[TBL] [Abstract][Full Text] [Related]
4. Biological effects of sex hormone-binding globulin on androgen-induced proliferation and androgen metabolism in LNCaP prostate cells.
Damassa DA; Lin TM; Sonnenschein C; Soto AM
Endocrinology; 1991 Jul; 129(1):75-84. PubMed ID: 2055206
[TBL] [Abstract][Full Text] [Related]
5. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells.
Arnold JT; Le H; McFann KK; Blackman MR
Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E573-84. PubMed ID: 15536203
[TBL] [Abstract][Full Text] [Related]
6. Paxillin regulates androgen- and epidermal growth factor-induced MAPK signaling and cell proliferation in prostate cancer cells.
Sen A; O'Malley K; Wang Z; Raj GV; Defranco DB; Hammes SR
J Biol Chem; 2010 Sep; 285(37):28787-95. PubMed ID: 20628053
[TBL] [Abstract][Full Text] [Related]
7. Specific
Larimer BM; Dubois F; Bloch E; Nesti S; Placzek M; Zadra G; Hooker JM; Loda M; Mahmood U
J Nucl Med; 2018 Oct; 59(10):1538-1543. PubMed ID: 29853654
[TBL] [Abstract][Full Text] [Related]
8. Selective cleavage of human sex hormone-binding globulin by kallikrein-related peptidases and effects on androgen action in LNCaP prostate cancer cells.
Sanchez WY; de Veer SJ; Swedberg JE; Hong EJ; Reid JC; Walsh TP; Hooper JD; Hammond GL; Clements JA; Harris JM
Endocrinology; 2012 Jul; 153(7):3179-89. PubMed ID: 22547569
[TBL] [Abstract][Full Text] [Related]
9. 6-(3,4-Dihydro-1H-isoquinoline-2-yl)-N-(6-methoxypyridine-2-yl) nicotinamide-26 (DIMN-26) decreases cell proliferation by induction of apoptosis and downregulation of androgen receptor signaling in human prostate cancer cells.
Choi HE; Shin JS; Leem DG; Kim SD; Cho WJ; Lee KT
Chem Biol Interact; 2016 Dec; 260():196-207. PubMed ID: 27720946
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of androgenic regulation by brefeldin A in androgen-responsive prostate cancer cells.
Alexander B; Fishman AI; Green D; Choudhury MS; Konno S
Urol Oncol; 2013 Jan; 31(1):104-9. PubMed ID: 21795077
[TBL] [Abstract][Full Text] [Related]
11. Prospective study of sex hormone levels and risk of prostate cancer.
Gann PH; Hennekens CH; Ma J; Longcope C; Stampfer MJ
J Natl Cancer Inst; 1996 Aug; 88(16):1118-26. PubMed ID: 8757191
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol inhibits DHT-induced progression of prostate cancer cell line through interfering with the AR and CXCR4 pathway.
Jang YG; Go RE; Hwang KA; Choi KC
J Steroid Biochem Mol Biol; 2019 Sep; 192():105406. PubMed ID: 31185279
[TBL] [Abstract][Full Text] [Related]
13. 5alpha-androstane-3alpha,17beta-diol supports human prostate cancer cell survival and proliferation through androgen receptor-independent signaling pathways: implication of androgen-independent prostate cancer progression.
Yang Q; Titus MA; Fung KM; Lin HK
J Cell Biochem; 2008 Aug; 104(5):1612-24. PubMed ID: 18320593
[TBL] [Abstract][Full Text] [Related]
14. Sex hormone-binding globulin influences gene expression of LNCaP and MCF-7 cells in response to androgen and estrogen treatment.
Kahn SM; Li YH; Hryb DJ; Nakhla AM; Romas NA; Cheong J; Rosner W
Adv Exp Med Biol; 2008; 617():557-64. PubMed ID: 18497082
[TBL] [Abstract][Full Text] [Related]
15. Dihydrotestosterone and testosterone levels in men screened for prostate cancer: a study of a randomized population.
Gustafsson O; Norming U; Gustafsson S; Eneroth P; Aström G; Nyman CR
Br J Urol; 1996 Mar; 77(3):433-40. PubMed ID: 8814852
[TBL] [Abstract][Full Text] [Related]
16. Bone extracellular matrix induces homeobox proteins independent of androgens: possible mechanism for androgen-independent growth in human prostate cancer cells.
Robbins SE; Shu WP; Kirschenbaum A; Levine AC; Miniati DN; Liu BC
Prostate; 1996 Dec; 29(6):362-70. PubMed ID: 8977633
[TBL] [Abstract][Full Text] [Related]
17. Characterization of androgen regulation of ZEB-1 and PSA in 22RV1 prostate cancer cells.
Anose BM; LaGoo L; Schwendinger J
Adv Exp Med Biol; 2008; 617():541-6. PubMed ID: 18497080
[TBL] [Abstract][Full Text] [Related]
18. Liprin-alpha2 gene, protein tyrosine phosphatase LAR interacting protein related gene, is downregulated by androgens in the human prostate cancer cell line LNCaP.
Fujinami K; Uemura H; Ishiguro H; Kubota Y
Int J Mol Med; 2002 Aug; 10(2):173-6. PubMed ID: 12119554
[TBL] [Abstract][Full Text] [Related]
19. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
20. HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes.
Axlund SD; Lambert JR; Nordeen SK
Mol Cancer Res; 2010 Dec; 8(12):1643-55. PubMed ID: 21047772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
